{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:10:09Z","timestamp":1790813409082,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministry of Science and Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ejps.2017.03.029","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T17:04:03Z","timestamp":1490375043000},"page":"221-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Bifunctional opioid\/nociceptin hybrid KGNOP1 effectively attenuates pain-related behaviour in a rat model of neuropathy"],"prefix":"10.1016","volume":"104","author":[{"given":"Joanna","family":"Starnowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Guillemyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioletta","family":"Makuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Mika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ballet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Przewlocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.03.029_bb0005","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1523\/JNEUROSCI.18-23-09685.1998","article-title":"Axotomy reduces the effect of analgesic opioids yet increases the effect of nociceptin on dorsal root ganglion neurons","volume":"18","author":"Abdulla","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2017.03.029_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2009.08.001","article-title":"Role of opioid receptors in the reduction of formalin-induced secondary allodynia and hyperalgesia in rats","volume":"619","author":"Ambriz-Tututi","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.03.029_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2017.03.029_bb0020","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.ejps.2017.03.029_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-2999(02)01833-2","article-title":"Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury","volume":"447","author":"Briscini","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.03.029_bb0030","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.bjp.0703169","article-title":"Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist","volume":"129","author":"Calo'","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.03.029_bb0035","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.bjp.0703219","article-title":"Pharmacology of nociceptin and its receptor: a novel therapeutic target","volume":"129","author":"Calo'","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.03.029_bb0040","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1529-8027.2006.0093.x","article-title":"Nociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processing","volume":"11","author":"Chen","year":"2006","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.ejps.2017.03.029_bb0045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/jpet.106.103960","article-title":"Endogenous Orphanin FQ\/nociceptin is involved in the development of morphine tolerance","volume":"318","author":"Chung","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.03.029_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0006-8993(01)02520-3","article-title":"The putative OP4 antagonist, [Nphe1]nociceptin(1-13)NH2, prevents the effects of nociceptin in neuropathic rats","volume":"905","author":"Corradini","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2017.03.029_bb0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pain.2004.03.037","article-title":"Evidence for an exclusive antinociceptive effect of nociceptin\/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain","volume":"110","author":"Courteix","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2017.03.029_bb0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pain.2004.03.037","article-title":"Evidence for an exclusive antinociceptive effect of nociceptin\/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain","volume":"110","author":"Courteix","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2017.03.029_bb0065","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(24)37095-8","article-title":"Binding and in vitro activities of peptides with high affinity for the nociceptin\/orphanin FQ receptor, ORL1","volume":"283","author":"Dooley","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.03.029_bb0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11916-014-0463-y","article-title":"Drug combinations in the treatment of neuropathic pain","volume":"18","author":"Eisenberg","year":"2014","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.ejps.2017.03.029_bb0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejmech.2014.12.033","article-title":"Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist \u2013 neurokinin-1 antagonist peptidomimetics","volume":"92","author":"Guillemyn","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2017.03.029_bb0080","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1021\/acs.jmedchem.5b01976","article-title":"Bifunctional peptide-based opioid agonist\u2013Nociceptin antagonist ligands for dual treatment of acute and neuropathic pain HHS public access","volume":"59","author":"Guillemyn","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2017.03.029_bb0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.pbb.2011.05.029","article-title":"Synergistic anti-allodynic effects of nociceptin\/orphanin FQ and cannabinoid systems in neuropathic mice","volume":"99","author":"Gunduz","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejps.2017.03.029_bb0090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0304-3959(98)00071-2","article-title":"Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin\/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation","volume":"76","author":"Hao","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2017.03.029_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pain.2009.10.026","article-title":"Long-lasting antinociceptive spinal effects in primates of the novel nociceptin\/orphanin FQ receptor agonist UFP-112","volume":"148","author":"Hu","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2017.03.029_bb0100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.03.029_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2006.12.015","article-title":"Anti-nociceptive and anti-allodynic effects of a high affinity NOP hexapeptide [Ac-RY(3-Cl)YRWR-NH2] (Syn 1020) in rodents","volume":"560","author":"Khroyan","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.03.029_bb0110","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1124\/jpet.106.111997","article-title":"SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin\/orphanin FQ\/mu-opioid receptor partial agonist: analgesic and rewarding properties in mice","volume":"320","author":"Khroyan","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.03.029_bb0115","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1124\/jpet.109.156711","article-title":"Nociceptin\/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin\/orphanin FQ\/\u03bc-opioid receptor agonists","volume":"331","author":"Khroyan","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.03.029_bb0120","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1124\/jpet.111.184663","article-title":"Differential effects of nociceptin\/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: studies with bifunctional NOP\/\u03bc receptor agonists in the sciatic nerve ligation chronic pain model in mice","volume":"339","author":"Khroyan","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.03.029_bb0125","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.2174\/138161281942140105165646","article-title":"Hybrid opioid\/non-opioid ligands in pain research","volume":"19","author":"Kleczkowska","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2017.03.029_bb0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(02)02052-6","article-title":"Buprenorphine alleviates neuropathic pain-like behaviors in rats after spinal cord and peripheral nerve injury","volume":"450","author":"Kouya","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.03.029_bb0135","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrd2572","article-title":"The nociceptin\/orphanin FQ receptor: a target with broad therapeutic potential","volume":"7","author":"Lambert","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2017.03.029_bb0140","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1021\/cn300124f","article-title":"The therapeutic potential of nociceptin\/orphanin FQ receptor agonists as analgesics without abuse liability","volume":"4","author":"Lin","year":"2013","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.ejps.2017.03.029_bb0145","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1124\/jpet.114.213694","article-title":"Cebranopadol: a novel potent analgesic nociceptin\/orphanin FQ peptide and opioid receptor agonist","volume":"349","author":"Linz","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.03.029_bb0150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neulet.2011.10.059","article-title":"Elevated prepronociceptin, nociceptin\/orphanin FQ and nocistatin concentrations in rat chronic constriction nerve injury and diabetic neuropathic pain models","volume":"506","author":"Liu","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejps.2017.03.029_bb0155","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.neuropharm.2013.08.031","article-title":"Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats","volume":"75","author":"Makuch","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejps.2017.03.029_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006146.pub2","article-title":"Opioids for neuropathic pain","volume":"8","author":"McNicol","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejps.2017.03.029_bb0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbi.2008.07.005","article-title":"Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice","volume":"23","author":"Mika","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejps.2017.03.029_bb0170","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.neuroscience.2009.11.064","article-title":"Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain","volume":"165","author":"Mika","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejps.2017.03.029_bb0175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.npep.2011.03.002","article-title":"The role of nociceptin and dynorphin in chronic pain: implications of neuro-glial interaction","volume":"45","author":"Mika","year":"2011","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejps.2017.03.029_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104420","article-title":"Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain","volume":"9","author":"Mika","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2017.03.029_bb0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3959(98)00196-1","article-title":"Heritability of nociception II. \u201cTypes\u201d of nociception revealed by genetic correlation analysis","volume":"80","author":"Mogil","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2017.03.029_bb0190","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/med.20197","article-title":"Development of nociceptin receptor (NOP) agonists and antagonists","volume":"31","author":"Mustazza","year":"2011","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejps.2017.03.029_bb0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pain.2005.03.012","article-title":"Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat","volume":"116","author":"Obara","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2017.03.029_bb0200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pain.2008.12.006","article-title":"Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain","volume":"141","author":"Obara","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2017.03.029_bb0205","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00019053-200927020-00002","article-title":"Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy","volume":"27","author":"O'Connor","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ejps.2017.03.029_bb0210","doi-asserted-by":"crossref","first-page":"762930","DOI":"10.1155\/2014\/762930","article-title":"Minocycline enhances the effectiveness of Nociceptin\/orphanin FQ during neuropathic pain","volume":"2014","author":"Popiolek-Barczyk","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ejps.2017.03.029_bb0215","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejphar.2014.08.011","article-title":"Pharmacogenomic study of the role of the nociceptin\/orphanin FQ receptor and opioid receptors in diabetic hyperalgesia","volume":"741","author":"Rutten","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.03.029_bb0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2015.01.049","article-title":"Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin\/orphanin FQ receptor and \u03bc-opioid receptor agonism","volume":"754","author":"Schiene","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.03.029_bb0225","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/ml500117c","article-title":"Discovery of a potent analgesic NOP and opioid receptor agonist: cebranopadol","volume":"5","author":"Schunk","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2017.03.029_bb0230","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0304-3940(90)90518-E","article-title":"A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats","volume":"115","author":"Shir","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejps.2017.03.029_bb0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1254\/jphs.13029SC","article-title":"Antihyperalgesic effect of buprenorphine involves nociceptin\/orphanin FQ peptide-receptor activation in rats with spinal nerve injury-induced neuropathy","volume":"122","author":"Takahashi","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2017.03.029_bb0240","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ejps.2017.03.029_bb0245","series-title":"Pharmacologic Treatment of Neuropathic Pain","author":"Wallace","year":"2001"},{"key":"10.1016\/j.ejps.2017.03.029_bb0250","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0196-9781(00)00234-5","article-title":"Nociceptin\/orphanin FQ in spinal nociceptive mechanisms under normal and pathological conditions","volume":"21","author":"Xu","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2017.03.029_bb0255","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","article-title":"Chronic catheterization of the spinal subarachnoid space","volume":"17","author":"Yaksh","year":"1976","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejps.2017.03.029_bb0260","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0301-0082(98)00067-7","article-title":"Nociceptin\/orphanin FQ: role in nociceptive information processing","volume":"57","author":"Yamamoto","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejps.2017.03.029_bb0265","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717301641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717301641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:11:04Z","timestamp":1750180264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717301641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":53,"alternative-id":["S0928098717301641"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.03.029","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bifunctional opioid\/nociceptin hybrid KGNOP1 effectively attenuates pain-related behaviour in a rat model of neuropathy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}